ProQR Therapeutics (PRQR) Other financing activities (2014 - 2025)

ProQR Therapeutics (PRQR) has reported Other financing activities for 12 consecutive years, with $76242.9 the latest figure, recorded in Q1 2025.

• Quarterly Other financing activities fell 58.64% year-over-year to $76242.9 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $275384.9 (down 23.66% YoY) and the FY2021 annual result came in at $1.7 million, up 106.53% from the prior year.
• Other financing activities improved to $76242.9 in Q1 2025 per PRQR's latest filing, from $1138.0 in the prior quarter.
• Over the last five years, Other financing activities for PRQR reached as high as $647496.0 in Q1 2021 and fell as low as $1138.0 in Q3 2024.
• A 5-year average of $201624.8 and a median of $171831.1 in 2023 frame the typical range for Other financing activities.
• Annual changes were most pronounced in 2021 — Other financing activities jumped 121221.96% — and 2024, when it tumbled 99.34%.
• Year by year, Other financing activities stood at $413077.4 in 2021, then slumped by 90.91% to $37552.5 in 2022, then jumped by 357.58% to $171831.1 in 2023, then slumped by 99.34% to $1138.0 in 2024, then jumped by 6600.0% to $76242.9 in 2025.
• According to Business Quant data, Other financing activities over the past three periods registered $76242.9, $1138.0, and $13655.5 for Q1 2025, Q3 2024, and Q2 2024 respectively.